Literature DB >> 22561794

Vaccine delivery carriers: insights and future perspectives.

J F Correia-Pinto1, N Csaba, M J Alonso.   

Abstract

Vaccination is undoubtedly the most effective health intervention for disease prevention and eradication. Nevertheless, currently there is still a need for improving immunization coverage worldwide. A promising strategy to achieve this goal nowadays relies on the use of delivery carriers capable of inducing an effective immune response and providing improved stability, safety and cost effectiveness. This article focuses on analyzing the critical aspects in the design of these carriers, and reviewing the state of the art of currently marketed formulations and those in advanced clinical development. These vaccine delivery carriers include emulsions, liposomes and polymeric particulate carriers. Finally, particular attention is given to the evolution in the design of polymeric nanocarriers, which have been receiving increasing attention and hold promise to generate novel platforms for needle-free administration and single-dose vaccination.
Copyright © 2012 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22561794     DOI: 10.1016/j.ijpharm.2012.04.047

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  21 in total

Review 1.  Potential applications of nanoparticles in cancer immunotherapy.

Authors:  Yimei Jia; Abdelwahab Omri; Lakshmi Krishnan; Michael J McCluskie
Journal:  Hum Vaccin Immunother       Date:  2016-11-21       Impact factor: 3.452

Review 2.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

3.  Current Prospects in Peptide-Based Subunit Nanovaccines.

Authors:  Prashamsa Koirala; Sahra Bashiri; Istvan Toth; Mariusz Skwarczynski
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Mucosal Vaccination: A Promising Alternative Against Flaviviruses.

Authors:  Rosendo Luria-Pérez; Luis A Sánchez-Vargas; Paola Muñoz-López; Gabriela Mellado-Sánchez
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

Review 5.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

6.  Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.

Authors:  Chompoonuch Sawaengsak; Yasuko Mori; Koichi Yamanishi; Ampol Mitrevej; Nuttanan Sinchaipanid
Journal:  AAPS PharmSciTech       Date:  2013-12-17       Impact factor: 3.246

7.  Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.

Authors:  Arjun Seth; Fiona K Ritchie; Nani Wibowo; Linda H L Lua; Anton P J Middelberg
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

8.  Just-in-time vaccines: Biomineralized calcium phosphate core-immunogen shell nanoparticles induce long-lasting CD8(+) T cell responses in mice.

Authors:  Weibin Zhou; Albanus O Moguche; David Chiu; Kaja Murali-Krishna; François Baneyx
Journal:  Nanomedicine       Date:  2013-11-22       Impact factor: 5.307

Review 9.  Peptide Vaccine: Progress and Challenges.

Authors:  Weidang Li; Medha D Joshi; Smita Singhania; Kyle H Ramsey; Ashlesh K Murthy
Journal:  Vaccines (Basel)       Date:  2014-07-02

Review 10.  Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease.

Authors:  Yong Taik Lim
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.